Bibliografisk note

Funding Information:
The research was supported by Rigshospitalets Research Foundation and the Novo Nordisk Foundation (Novo Nordisk Foundation Center for Stem Cell Biology, DanStem; grant NNF17CC0027852). The project is part of the Danish Research Center for Precision Medicine in Blood Cancers funded by the Danish Cancer Society grant no. R223-A13071 and Greater Copenhagen Health Science Partners. The clinical trial was investigator-initiated and supported by Janssen and Celgene.